Compositions and methods for screening therapeutic agents

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 19/00 (2006.01) A61K 38/17 (2006.01) A61K 38/46 (2006.01) A61K 47/48 (2006.01) A61P 3/00 (2006.01) C07K 14/47 (2006.01) C12N 9/14 (2006.01)

Patent

CA 2400802

Methods and models for transporting agents across the blood brain barrier, the preparation of antibodies and antisense oligonucleotides, the preparation of experimental systems to study murine p97, the isolation of substances that modulate murine p97 expression and/or activity as well as the use of the murine p97 nucleic acid sequences and proteins and modulators thereof in diagnostic and therapeutic applications are described.

L'invention concerne des procédés et des modèles de transport d'agents à travers la barrière hémato-encéphalique, la préparation d'anticorps et d'oligonucléotides antisens, la préparation de systèmes expérimentaux pour l'étude de murine p97, l'isolation de substances qui modulent l'expression et/ou l'activité de murine p97 ainsi que l'utilisation des séquences d'acide nucléique de murine p97, de leurs protéines et de leurs modulateurs dans des applications diagnostiques et thérapeutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for screening therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for screening therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for screening therapeutic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2017650

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.